Lets Add Gemany based Agennix and Eisai's Failed Trials that's 5.That's why they call it the Sepsis Graveyard.IMO This is why EAP Will be Big News us and also the stock price.How high,who knows.
They pulled the plug on the deal in 2012 and a year earlier Lilly pulled the plug on Xigris.Imo We could have a very HUGE Winner here!
How much just for Sepsis would we be worth after FDA Approval?AstraZeneca signed a Drug Deal for Sepsis with Cytofab in 2005,10 years ago for $338 Million.
warren I think we will hear who the cardiac partner is soon after the EAP .IMO They are waiting for it just like we are.Looks better to announce after the FDA big news.
$14 might be close.The next day it could go a hair higher since this is Sepsis and we are already doing an FDA Cardiac Surgery Trial.Double the attention to Cytosorb on the street.JMO
From Germany.Looks like they are adding it to Cytosorb.
Long but good.IMO Helps explain why we have a real winner here.Plus we just learned Cytosorb helps to reduce this.
Article from The UK.Notice the part Regain Control.Plus the part about Septic Shock.
Cytosorb seems to reduce billirubin levels better than MARS and Fresenius Prometheus Filter.Last case Report was around 66 percent.
The same goes for Sepsis.It is one of the major causes of AKI.30% to 50%.Kellum mentioned a while back about even doing a trial with Cytosorb and AKI.I guess they figured on going after a much bigger Piece of the Pie.Multi-Organ Failure.
Probably the results from the FDA Refresh Study in Feb.Acute kidney Injury is a great burden for patients undergoing Cardiac Surgery and can effect the short-term and long-term prognoses of patients.This is where Cytosorb seems to work best AKI.
Thanks andy.Seems there is alway somebody from the medical community talking about Cytosorb.